Expanding the genomic roadmap of Alzheimer's disease

The Lancet Neurology

Volumn 14, Issue 8, 2015, Pages 783-785

  Farrer, Lindsay A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; ATP BINDING CASSETTE TRANSPORTER PROTEIN 7; PRESENILIN 1; PRESENILIN 2; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; APOE EPSILON4 GENE; AUTOSOMAL DOMINANT INHERITANCE; DNA SEQUENCE; EPIGENETICS; FRAMESHIFT MUTATION; GENE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HERITABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; LOSS OF FUNCTION MUTATION; NEXT GENERATION SEQUENCING; NONHUMAN; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE; GENETICS; MALE; PROCEDURES;

ALZHEIMER DISEASE; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GENE FREQUENCY; HUMANS; MALE; SEQUENCE ANALYSIS, DNA;

EID: 84937521532     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00146-5     Document Type: Note

References (11)

1. Sherva R, Farrer LA Power and pitfalls of the genome wide association study approach to identify genes for Alzheimer disease. Curr Psych Rep 2011, 13:138-146.
2. Lambert J-C, Ibrahim-Verbaas CA, Harold D, et al. Extended meta-analysis of 74,538 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013, 45:1452-1458.
3. Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 2013, 368:107-116.
4. Guerreiro R, Wojtas A, Bras J, et al. TREM2 variants in Alzheimer's disease. N Engl J Med 2013, 368:117-127.
5. Wetzel-Smith MK, Hunkapiller J, Bhangale TR, et al. A rare mutation in UNC5C predisposes to Alzheimer's disease and increases neuronal cell death. Nature Med 2014, 20:1452-1457.
6. Logue MW, Schu M, Vardarajan BN, et al. Two rare AKAP9 missense variants are associated with Alzheimer disease in African Americans. Alzheimers Dement 2014, 10:609-618.
7. Cuyvers E, De Roeck A, Van den Bossche T, et al. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study. Lancet Neurol 2015, published online July 1. http://dx.doi.org/10.1016/S1474-4422(15)00133-7.
8. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011, 43:429-435.
9. Naj AC, Jun G, Beecham GW, et al. Genome-wide association study of late-onset Alzheimer disease identifies disease associated variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1. Nat Genet 2011, 43:436-441.
10. Kim WS, Li H, Ruberu K, et al. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease. J Neurosci 2013, 33:4387-4394.
11. Steinberg S, Stefansson H, Jonsson T, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet 2015, 47:445-447.